MAGEA2 (MAGE family member A2)

2003-06-01  

Identity

HGNC
LOCATION
Xq28
LOCUSID
ALIAS
CT1.2,MAGE2,MAGEA2A

Other Information

Locus ID:

NCBI: 4101
MIM: 300173
HGNC: 6800
Ensembl: ENSG00000268606

Variants:

dbSNP: 4101
ClinVar: 4101
TCGA: ENSG00000268606
COSMIC: MAGEA2

RNA/Proteins

Gene IDTranscript IDUniprot
ENSG00000268606ENST00000595583P43356
ENSG00000268606ENST00000595583A0A024RC17
ENSG00000268606ENST00000598543P43356
ENSG00000268606ENST00000598543A0A024RC17
ENSG00000268606ENST00000611557P43356
ENSG00000268606ENST00000611557A0A024RC17
ENSG00000268606ENST00000611674P43356
ENSG00000268606ENST00000611674A0A024RC17
ENSG00000268606ENST00000617505E7ENJ0
ENSG00000268606ENST00000617846A0A087WZT8
ENSG00000268606ENST00000620710P43356
ENSG00000268606ENST00000620710A0A024RC17
ENSG00000268606ENST00000623438P43356
ENSG00000268606ENST00000623438A0A024RC17
ENSG00000268606ENST00000623806P43356
ENSG00000268606ENST00000623806A0A024RC17

Expression (GTEx)

0
1

References

Pubmed IDYearTitleCitations
389258152024hMAGEA2 Accelerates the Progression of Prostate Cancer via the EFNA3-Erk1/2 Signaling Pathway.0
389258152024hMAGEA2 Accelerates the Progression of Prostate Cancer via the EFNA3-Erk1/2 Signaling Pathway.0
348375452022Overexpression of melanoma-associated antigen A2 has a clinical significance in embryonal carcinoma and is associated with tumor progression.1
348375452022Overexpression of melanoma-associated antigen A2 has a clinical significance in embryonal carcinoma and is associated with tumor progression.1
327721472021Reduced cytoplasmic expression of MAGE-A2 predicts tumor aggressiveness and survival: an immunohistochemical analysis.2
327721472021Reduced cytoplasmic expression of MAGE-A2 predicts tumor aggressiveness and survival: an immunohistochemical analysis.2
300642322018Melanoma-associated antigen A2 is overexpressed in glioma and associated with poor prognosis in glioma patients.3
300642322018Melanoma-associated antigen A2 is overexpressed in glioma and associated with poor prognosis in glioma patients.3
284157492017hMAGEA2 promotes progression of breast cancer by regulating Akt and Erk1/2 pathways.3
284984552017Overexpression of MAGEA2 has a prognostic significance and is a potential therapeutic target for patients with lung cancer.4
284157492017hMAGEA2 promotes progression of breast cancer by regulating Akt and Erk1/2 pathways.3
284984552017Overexpression of MAGEA2 has a prognostic significance and is a potential therapeutic target for patients with lung cancer.4
266753542016Prognostic Implication of Lymphovascular Invasion Detected by Double Immunostaining for D2-40 and MITF1 in Primary Cutaneous Melanoma.4
266753542016Prognostic Implication of Lymphovascular Invasion Detected by Double Immunostaining for D2-40 and MITF1 in Primary Cutaneous Melanoma.4
260010712015MAGE-A Cancer/Testis Antigens Inhibit MDM2 Ubiquitylation Function and Promote Increased Levels of MDM4.22

Citation

Dessen P

MAGEA2 (MAGE family member A2)

Atlas Genet Cytogenet Oncol Haematol. 2003-06-01

Online version: http://atlasgeneticsoncology.org/gene/41245/magea2